Kopran Limited (BOM:524280)

Market Cap	7.88B -14.1%
Revenue (ttm)	6.81B +8.2%
Net Income	257.31M -33.3%
EPS	5.33 -33.2%
Shares Out	48.29M
PE Ratio	30.62
Forward PE	n/a
Dividend	3.00 (1.84%)
Ex-Dividend Date	Sep 4, 2025

Volume	16,317
Average Volume	28,657
Open	168.05
Previous Close	168.05
Day's Range	162.60 - 169.15
52-Week Range	107.00 - 212.50
Beta	0.76
RSI	55.48
Earnings Date	May 19, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 1,024
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524280

Financial Performance

In fiscal year 2026, Kopran's revenue was 6.81 billion, an increase of 8.23% compared to the previous year's 6.30 billion. Earnings were 257.31 million, a decrease of -33.26%.